Robert G. Mitchell, senior manager, contrast imaging solutions, explains how Bracco Diagnostics' acquisition of E-Z-EM further positions the company as a global leader in diagnostic imaging in radiology and cardiology. The merger allows for significant growth opportunities as E-Z-EM complements Bracco's comprehensive repertoire of diagnostic imaging agents. The synergies among both companies' product portfolios, complementary customer bases and technical expertise will strengthen Bracco Diagnostics' position in the evolving field of imaging informatics and patient management.
Related Content
News | Radiology Business
Nov. 13, 2025 — Covera Health recently announced that Advanced Radiology Services (ARS) has joined its national Quality ...
November 17, 2025 
News | Interventional Radiology
Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...
November 13, 2025 
News | Radiology Business
Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...
November 13, 2025 
News | Orthopedic Imaging
Nov.10, 2025 — Medical imaging technology company Adaptix Ltd. has received 510(k) clearance from the U.S. Food and Drug ...
November 11, 2025 
Nov. 10, 2025 — There has been substantial progress in the past few years in the field of MRI in general and remote MR ...
November 11, 2025 
News | Contrast Media
Nov. 10, 2025 — Scientists at the University of Birmingham have developed a new class of MRI contrast agents – improving ...
November 10, 2025 
Feature | Teleradiology | Kyle Hardner
Once viewed as a solution for after-hours coverage, teleradiology is rapidly expanding into a critical part of radiology ...
November 06, 2025 
News | X-Ray
Oct. 30, 2025 – In collaboration with OBIO, University Health Network (UHN), Canada’s leading hospital and the No. 1 ...
November 03, 2025 
News | Magnetic Resonance Imaging (MRI) | Children's Hospital Los Angeles
Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme ...
October 31, 2025 
News | FDA
Oct. 30, 2025 — Sirona Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona ...
October 30, 2025 